Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Non Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Revenue (2016 - 2024)

Historic Revenue for Summit Therapeutics (SMMT) over the last 7 years, with Q2 2024 value amounting to -$3.1 million.

  • Summit Therapeutics' Revenue changed N/A to -$3.1 million in Q2 2024 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $705000.0 for FY2022, which is 6102.82% down from last year.
  • Summit Therapeutics' Revenue amounted to -$3.1 million in Q2 2024.
  • Summit Therapeutics' Revenue's 5-year high stood at $324311.9 during Q1 2020, with a 5-year trough of -$3.1 million in Q1 2024.
  • For the 3-year period, Summit Therapeutics' Revenue averaged around -$1.4 million, with its median value being -$1.4 million (2022).
  • Over the last 5 years, Summit Therapeutics' Revenue had its largest YoY gain of 3357.02% in 2020, and its largest YoY loss of 3357.02% in 2020.
  • Summit Therapeutics' Revenue (Quarter) stood at $324311.9 in 2020, then plummeted by 32.16% to $220000.0 in 2022, then tumbled by 1510.0% to -$3.1 million in 2024.
  • Its last three reported values are -$3.1 million in Q2 2024, -$3.1 million for Q1 2024, and $220000.0 during Q3 2022.